HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Septelia I Wanandi Selected Research

S-acetylthiorphan

5/2022Conjugation of Cetuximab - Puromycin and Its Target-Specific Effect on Triple Negative Breast Cancer Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Septelia I Wanandi Research Topics

Disease

3Neoplasms (Cancer)
05/2022 - 06/2014
3Hypoxia (Hypoxemia)
10/2011 - 01/2010
1Triple Negative Breast Neoplasms
05/2022
1Breast Neoplasms (Breast Cancer)
09/2020
1Mouth Neoplasms (Oral Cancer)
06/2014
1Squamous Cell Carcinoma of Head and Neck
06/2014
1Reperfusion Injury
04/2013
1Tetralogy of Fallot (Fallot Tetralogy)
04/2013
1Body Weight (Weight, Body)
04/2013

Drug/Important Bio-Agent (IBA)

1ErbB Receptors (EGF Receptor)IBA
05/2022
1Cetuximab (Erbitux)FDA Link
05/2022
1Monoclonal AntibodiesIBA
05/2022
1PuromycinIBA
05/2022
1S-acetylthiorphanIBA
05/2022
1SurvivinIBA
09/2020
1RotenoneIBA
09/2020
1sepantroniumIBA
09/2020
1ChitosanIBA
06/2014
1Cisplatin (Platino)FDA LinkGeneric
06/2014
1Biocompatible Materials (Biomaterials)IBA
06/2014
1Allopurinol (Remid)FDA LinkGeneric
04/2013
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
10/2011
1Transcription Factors (Transcription Factor)IBA
10/2011
1Polymethyl Methacrylate (Sol)IBA
07/2010
1Messenger RNA (mRNA)IBA
01/2010

Therapy/Procedure

2Therapeutics
05/2022 - 09/2020
1Drug Therapy (Chemotherapy)
05/2022
1Molecular Targeted Therapy
09/2020